Alltrna: Creating the tRNA modality
Flagship’s latest RNA company Alltrna aims to pioneer tRNA therapies
Flagship-launched Alltrna is building on recent mRNA momentum with a platform designed to uncover the therapeutic potential of another type of RNA — tRNA — and turn it into an entirely new therapeutic modality.
The company was launched under Flagship Pioneering’s incubation model with $50 million in committed capital from the VC and a plan to develop therapeutics that alter protein expression at the final step of the synthesis process. ...